Pneumovax 23 Injection, Solution
NDC Package 0006-4837-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Pneumovax 23 (pneumococcal vaccine polyvalent) injection is this vaccine helps protect against serious infection (e.g., meningitis, bacteria in the blood) due to certain bacteria (Streptococcus pneumoniae). This formulation utilizes a injection, solution delivery system. Marketed by Merck Sharp & Dohme Llc, this product is identified by NDC 0006-4837 and is authorized under FDA application BLA101094.

Identification & Billing

NDC Package Code
0006-4837-03
Package Description
10 SYRINGE, GLASS in 1 CARTON / .5 mL in 1 SYRINGE, GLASS (0006-4837-01)
Product Code
0006-4837
11-Digit Billing Format
00006483703
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 1547580 - pneumococcal 23-valent polysaccharide vaccine (PPSV23) 0.5 ML Prefilled Syringe
  • RxCUI: 1547580 - 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 12F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 14 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 15B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 17F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 18C capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 2 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 20 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 22F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 23F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 3 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 33F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 4 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 5 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 6B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 7F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 8 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9N capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9V capsular polysaccharide antigen 0.05 MG/ML Prefilled Syringe
  • RxCUI: 1547580 - pneumococcal vaccine 23-polyvalent 0.5 ML Prefilled Syringe
  • RxCUI: 1547582 - PNEUMOVAX 23 vaccine 0.5 ML Prefilled Syringe
  • RxCUI: 1547582 - 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 12F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 14 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 15B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 17F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 18C capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 2 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 20 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 22F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 23F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 3 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 33F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 4 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 5 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 6B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 7F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 8 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9N capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9V capsular polysaccharide antigen 0.05 MG/ML Prefilled Syringe [Pneumovax 23]

Clinical Specifications

Proprietary Name
Pneumovax 23
Non-Proprietary Name
Pneumococcal Vaccine Polyvalent
Substance Name
Streptococcus Pneumoniae Type 1 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 10a Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 11a Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 12f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 14 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 15b Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 17f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 18c Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 19a Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 19f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 2 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 20 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 22f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 23f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 3 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 33f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 4 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 5 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 6b Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 7f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 8 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 9n Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 9v Capsular Polysaccharide Antigen
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This vaccine helps protect against serious infection (e.g., meningitis, bacteria in the blood) due to certain bacteria (Streptococcus pneumoniae). This vaccine is important for preventing infection in individuals at risk (e.g., those with heart disease, lung disease, liver disease, diabetes, alcoholism, spleen problems, sickle cell anemia, or HIV, or those living in a nursing home).

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Llc
Product Type
Vaccine
FDA Application #
BLA101094
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
07-21-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

90732
Source: AWP
PPSV23 VACC 2 YRS+ SUBQ/IM
HCPCS Dosage 0.5 ML
Units / Pkg 10

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0006-4837-03 identifies a specific commercial package of 10 syringe, glass in 1 carton / .5 ml in 1 syringe, glass (0006-4837-01) of Pneumovax 23, a vaccine label labeled by Merck Sharp & Dohme Llc. This injection, solution is formulated for intramuscular; subcutaneous use and contains streptococcus pneumoniae type 1 capsular polysaccharide antigen; streptococcus pneumoniae type 10a capsular polysaccharide antigen; streptococcus pneumoniae type 11a capsular polysaccharide antigen; streptococcus pneumoniae type 12f capsular polysaccharide antigen; streptococcus pneumoniae type 14 capsular polysaccharide antigen; streptococcus pneumoniae type 15b capsular polysaccharide antigen; streptococcus pneumoniae type 17f capsular polysaccharide antigen; streptococcus pneumoniae type 18c capsular polysaccharide antigen; streptococcus pneumoniae type 19a capsular polysaccharide antigen; streptococcus pneumoniae type 19f capsular polysaccharide antigen; streptococcus pneumoniae type 2 capsular polysaccharide antigen; streptococcus pneumoniae type 20 capsular polysaccharide antigen; streptococcus pneumoniae type 22f capsular polysaccharide antigen; streptococcus pneumoniae type 23f capsular polysaccharide antigen; streptococcus pneumoniae type 3 capsular polysaccharide antigen; streptococcus pneumoniae type 33f capsular polysaccharide antigen; streptococcus pneumoniae type 4 capsular polysaccharide antigen; streptococcus pneumoniae type 5 capsular polysaccharide antigen; streptococcus pneumoniae type 6b capsular polysaccharide antigen; streptococcus pneumoniae type 7f capsular polysaccharide antigen; streptococcus pneumoniae type 8 capsular polysaccharide antigen; streptococcus pneumoniae type 9n capsular polysaccharide antigen; streptococcus pneumoniae type 9v capsular polysaccharide antigen as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Merck Sharp & Dohme Llc on July 21, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This vaccine helps protect against serious infection (e.g., meningitis, bacteria in the blood) due to certain bacteria (Streptococcus pneumoniae). This vaccine is important for preventing infection in individuals at risk (e.g., those with heart disease, lung disease, liver disease, diabetes, alcoholism, spleen problems, sickle cell anemia, or HIV, or those living in a nursing home).

How is this Merck Sharp & Dohme Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00006483703. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0006-4837-03
11-Digit CMS (5-4-2)
00006-4837-03

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.